TFS
ALT icon

TrustCore Financial Services’s Altimmune ALT Stock Holding History

TrustCore Financial Services’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-250
Closed -$3K – 833
2020
Q2 		$3K Sell
250
-200
-44% -$1.1K ﹤0.01% 750
2020
Q1 		$1K Buy
+450
New +$1.03K ﹤0.01% 807

Other funds holding ALT

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

TrustCore Financial Services's ALT Position: Q3 2020 in Review

TrustCore Financial Services sold out of Altimmune (ALT) in Q3 2020, closing a stake of 250 shares — an estimated $3K sold.

TrustCore Financial Services first reported a position in ALT in Q1 2020 and held it in 2 quarters. The position peaked at $3K in Q2 2020. 72 funds tracked by Wall St. Rank hold ALT as of Q3 2020.

  • TrustCore Financial Services reported no remaining Altimmune position as of Q3 2020 after selling out during the quarter.
  • TrustCore Financial Services sold 250 Altimmune shares in Q3 2020, an estimated $3K.
  • TrustCore Financial Services first reported a position in Altimmune in Q1 2020 and held it in 2 quarters.
  • TrustCore Financial Services's Altimmune position peaked at $3K in Q2 2020.
  • 72 funds tracked by Wall St. Rank held Altimmune as of Q3 2020.

Based on TrustCore Financial Services's 13F filing for Q3 2020, filed 2 Nov 2020.